ViaDerma Provides an Update on Current & Future Business Activities
02. März 2023 08:00 ET
|
ViaDerma, Inc.
LOS ANGELES, March 02, 2023 (GLOBE NEWSWIRE) -- ViaDerma, Inc. (OTC Pink: VDRM) is pleased to provide an update on current business activities. ViaDerma has expanded its licensing agreement with a...
ViaDerma Engages Intent Sciences to Power Up Digital Marketing & Brand Development
12. Januar 2023 08:00 ET
|
ViaDerma, Inc.
LOS ANGELES, Jan. 12, 2023 (GLOBE NEWSWIRE) -- ViaDerma, Inc., (OTC Pink: VDRM) is pleased to announce that they have engaged the growth marketing services of INTENT SCIENCES who will help grow the...
ViaDerma Successfully Completes Quality Control Testing of its New Vitastem Products
15. September 2022 05:00 ET
|
ViaDerma, Inc.
LOS ANGELES, Sept. 15, 2022 (GLOBE NEWSWIRE) -- ViaDerma, Inc., (“Company”) (OTC Pink: VDRM) announces the successful completion of its internal quality control testing for their new Vitastem...
ViaDerma Announces the Implementation of Internal Quality Control Measures for its New Vitastem Products
22. Juni 2022 09:00 ET
|
ViaDerma, Inc.
LOS ANGELES, June 22, 2022 (GLOBE NEWSWIRE) -- ViaDerma, Inc., (“Company”) (OTC Pink: VDRM) announces plans to conduct additional internal quality control testing for their new Vitastem products....
ViaDerma's 2021 Annual Report Shows Strong Revenue Growth Over the Previous Year
31. März 2022 05:00 ET
|
ViaDerma, Inc.
LOS ANGELES, March 31, 2022 (GLOBE NEWSWIRE) -- ViaDerma, Inc., (“Company”) (OTC Pink: VDRM) announces the release of its 2021 Annual Report on the OTC Markets. The Company ended the year with...
ViaDerma, Inc. Set to Launch Two New and Improved Versions of its Flagship Product, Vitastem and Vitastem Ultra
04. Oktober 2021 05:00 ET
|
ViaDerma, Inc.
LOS ANGELES, Oct. 04, 2021 (GLOBE NEWSWIRE) -- ViaDerma, Inc., (“Company”) (OTC Pink: VDRM) is pleased to announce they are launching two new and improved formulas for its top selling product,...
ViaDerma, Inc. Files Amended Financial Statements
24. August 2021 10:23 ET
|
ViaDerma, Inc.
LOS ANGELES, Aug. 24, 2021 (GLOBE NEWSWIRE) -- ViaDerma, Inc., (“Company”) (OTC Pink: VDRM) published a Quarterly Report for the three months ended March 31, 2021, on the OTC Markets website...
ViaDerma, Inc. Provides Updates on Current Business Activities
24. Juni 2021 05:00 ET
|
ViaDerma, Inc.
LOS ANGELES, June 24, 2021 (GLOBE NEWSWIRE) -- ViaDerma, Inc., (“Company”) (OTC Pink: VDRM), is pleased to provide an update on current business activities. The Company has finalized a ten-year $12...
ViaDerma, Inc. Announces Expansion of its Current Licensing Agreement and Provides Additional Company Updates
02. Juni 2021 05:00 ET
|
ViaDerma, Inc.
LOS ANGELES, June 02, 2021 (GLOBE NEWSWIRE) -- ViaDerma, Inc., (“Company”) (OTC Pink: VDRM), is pleased to announce they have expanded their current licensing agreement with a home health wound care...
ViaDerma, Inc. Nearing Initial Order from Large Hospital Network
13. Mai 2021 05:00 ET
|
ViaDerma, Inc.
LOS ANGELES, May 13, 2021 (GLOBE NEWSWIRE) -- ViaDerma, Inc., (“Company”) (OTC Pink: VDRM), announced they are nearing the end of their discussions with a major healthcare network to finalize an...